HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Bemethyl

HCID 9816609
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
109628-14-0
Standard SMILES
Br.CCSc1nc2ccccc2[nH]1
InChIKey
BKUKXOMYGPYFJJ-UHFFFAOYSA-N
Molecular formula
C9H11BrN2S
Average molar mass
259.17 g/mol
Monoisotopic mass
257.98263

Overview

2-mercaptobenzimidazole deriv.; alkylating agent and mutagen antagonist

Names & identifiers

Preferred name
Bemethyl
IUPAC
2-ethylsulfanyl-1H-benzimidazole;hydrobromide
English name
1H-BenziMidazole, 2-(ethylthio)-, MonohydrobroMide
Molecular formula
C9H11BrN2S
Molecular weight
259.16604

Names & synonyms

BemethylBemitil63513-71-3BemetilBemythylDTXSID00212924RefChem:916818DTXCID30135415bemithyl109628-14-02-(ETHYLSULFANYL)-1H-1,3-BENZODIAZOLE HYDROBROMIDEAntihot
Show more names
BemitonBetamylMetaprot2-ethylsulfanyl-1H-benzimidazole;hydrobromide1H-BENZIMIDAZOLE, 2-(ETHYLTHIO)-, MONOHYDROBROMIDETG4SAK8A5M2-Ethylsulfanyl-1H-benzimidazole hydrobromide2-(Ethylthio)benzimidazole hydrobromide

Database identifiers

CAS
109628-14-0、63513-71-3
PubChem CID
9816609
DTXSID
DTXSID00212924
UNII
TG4SAK8A5M

Properties

Computed structural propertiesFilling in

Topological polar surface area
54 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
13
Formal charge
0
Complexity
151

Physicochemical properties

FDA UNII
4 SAK8A5M · TG4SAK8A5M

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.

Drugs used to prevent SEIZURES or reduce their severity.

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes